A detailed history of Bridgewater Advisors Inc. transactions in Novartis Ag stock. As of the latest transaction made, Bridgewater Advisors Inc. holds 11,423 shares of NVS stock, worth $1.19 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
11,423
Previous 11,197 2.02%
Holding current value
$1.19 Million
Previous $1.19 Million 10.15%
% of portfolio
0.14%
Previous 0.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$106.13 - $120.89 $23,985 - $27,321
226 Added 2.02%
11,423 $1.31 Million
Q2 2024

Aug 01, 2024

BUY
$92.57 - $107.37 $1.04 Million - $1.2 Million
11,197 New
11,197 $1.19 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Bridgewater Advisors Inc. Portfolio

Follow Bridgewater Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Advisors Inc. with notifications on news.